M MENARINI MENARINI INTERNATIONAL
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

M MENARINI MENARINI INTERNATIONAL Trademark

Serial Number: 86794917 • Registration: 5748075

M MENARINI MENARINI INTERNATIONAL is a trademark filed by A.MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l. on October 21, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

A.MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l. (25 trademarks)

Via dei Sette Santi No.3
50131 FIRENZE , IT

Entity Type: 03

Trademark Details

Filing Date

October 21, 2015

Registration Date

May 14, 2019

Published for Opposition

April 5, 2016

Cancellation Date

November 28, 2025

Goods & Services

Pharmaceutical products and preparations for the treatment of disorders of the alimentary tract and metabolism, stomatological preparations, antacids, drugs for functional gastrointestinal disorders, antiemetics, antinauseants, drugs for bile and liver therapy, laxatives, antidiarrheals, intestinal antiinflammatory/antiinfective agents, antiobesity preparations, digestives including enzymes, drugs used in diabetes, insulins and analogues, blood glucose lowering drugs, vitamins, mineral supplements, tonics, anabolic agents for systemic use, appetite stimulants, amino acids and derivatives, enzymes antithrombotics, antihemorrhagics, antianemics, blood substitutes and perfusion solutions, hematological agents, cardiovascular drugs, cardiac drugs, vasodilators, antihypertensives, diuretics, peripheral vasodilators, vasoprotectives, beta blocking agents, calcium channel blockers, agents acting on the renin-angiotensin system, lipid modifying agents, dermatoiogicals, antifungals for dermatological use, emollients, protectives, preparations for treatment of wounds and ulcers, antipruritics including antihistamines, anesthetics, antipsoriatics, antibiotics and chemotherapeutics for dermatological use, corticosteroids for dermatological use, antiseptics, disinfectants, medicated dressings, anti-acne preparations, medical shampoos, genito urinary system drugs, gynecological antiinfectives and antiseptics, oxytocics, contraceptives for topical use, sympathomimetics, labour repressants, prolactine inhibitors, antiinflammatory products for vaginal administration, sex hormones and modulators of the genital system, hormonal contraceptives for systemic use, urologicals including antispasmodics, benign prostatic hypertrophy drugs, systemic hormonal preparations, pituitary and hypothalamic hormones and analogues, corticosteroids for systemic use, thyroid preparations, pancreatic hormones, parathyroid hormones and analogues, anti-parathyroid agents, antiinfectives, antibacterials and antimycotics for systemic use, antivirals for systemic use, immune sera and immunoglobulins, vaccines, antineoplastic and immunomodulating agents, endocrine drugs, immunostimulants, immunosuppressants, musculo-skeletal system drugs, antiinflammatory and antirheumatic products, topical products for joint and muscular pain, muscle relaxants, antigout preparations, drugs for treatment of bone diseases, central nervous system drugs, anesthetics, analgesics, antipyretics, antimigraine preparations, antiepileptics, anti-parkinson drugs, psycholeptics, antipsychotics, anxiolytics, hypnotics, sedatives, psychoanaleptics, antidepressants, psychostimulants, anti-dementia drugs, parasympathomimetics, drugs used in addictive disorders, antivertigos, antiparasitics, insecticides, repellents, respiratory system drugs, nasal preparations, throat preparations, drugs for obstructive airway diseases, inhalants, cough and cold preparations, antihistamines for systemic use, lung surfactants, respiratory stimulants, ophthalmologicals, otologicals, allergens, antidotes, iron chelating agents, antihyperkalemics, antihyperphosphatemics, detoxyfying agents for antineoplastic treatment, antihypercalcemics, antihypoglycemics, drugs for embolisation, medical gases, nerve depressants, diagnostic agents, diet formulations for treatment of obesity, infant formulas, contrast media, diagnostic and therapeutic radiopharmaceuticals, surgical dressings

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 28, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 14, 2024 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 15, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 15, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 15, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 15, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 15, 2023 COAR
REGISTERED-PRINCIPAL REGISTER
May 14, 2019 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Apr 10, 2019 DP1B
NOTICE OF ALLOWANCE CANCELLED
Apr 4, 2019 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Apr 4, 2019 D1BR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 16, 2018 EXRA
SOU EXTENSION 5 GRANTED
Oct 13, 2018 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 13, 2018 AITU
SOU EXTENSION 5 FILED
Oct 4, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 4, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 12, 2018 EXRA
SOU EXTENSION 4 GRANTED
May 10, 2018 EX4G
SOU EXTENSION 4 FILED
May 10, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
May 10, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 29, 2017 EXRA
SOU EXTENSION 3 GRANTED
Nov 27, 2017 EX3G
SOU EXTENSION 3 FILED
Nov 27, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 27, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2017 EXRA
SOU EXTENSION 2 GRANTED
May 8, 2017 EX2G
SOU EXTENSION 2 FILED
May 8, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
May 8, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 25, 2016 EXRA
SOU EXTENSION 1 GRANTED
Nov 23, 2016 EX1G
SOU EXTENSION 1 FILED
Nov 23, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 23, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 31, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 5, 2016 NPUB
PUBLISHED FOR OPPOSITION
Apr 5, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 16, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 29, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 22, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 22, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 22, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 22, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 22, 2016 CNEA
DATA MODIFICATION COMPLETED
Feb 18, 2016 DMCC
ASSIGNED TO EXAMINER
Feb 11, 2016 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Dec 9, 2015 AMPX
ASSIGNED TO LIE
Dec 8, 2015 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 20, 2015 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 27, 2015 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2015 NWOS
NEW APPLICATION ENTERED
Oct 24, 2015 NWAP